Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference
Theratechnologies (TSX: TH, NASDAQ: THTX), a biopharmaceutical company, announced that its President and CEO, Paul Levesque, will participate in a fireside chat at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021, at 2:00 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Theratechnologies (TSX: TH, NASDAQ: THTX), a biopharmaceutical company, announced that its President and CEO, Paul Levesque, will participate in a fireside chat at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021, at 2:00 p.m. ET. Investors can access a live webcast through the investor relations section of the company's website, with an archive available for 90 days post-event.
The company focuses on developing innovative therapies to address unmet medical needs.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was +1.71%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will participate in a fireside chat at the Canaccord Genuity 41st Annual Growth Conference on Wednesday, August 11, 2021 at 2:00 p.m. ET.
A live webcast of the event can be accessed through the investor relations section of the Company’s website under ‘Events’. An archive will also be available for 90 days following the event.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov
For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800
For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
ir@theratech.com
617-356-1009
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.